Cross Country Healthcare, Inc. (CCRN)
USD 13.99
(-0.04%)
USD 13.99
(-0.04%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 432.06 Million USD | -31.17% |
| 2022 | 627.68 Million USD | 67.38% |
| 2021 | 374.99 Million USD | 84.97% |
| 2020 | 202.73 Million USD | -0.63% |
| 2019 | 204 Million USD | -2.65% |
| 2018 | 209.56 Million USD | -8.32% |
| 2017 | 228.58 Million USD | 3.09% |
| 2016 | 221.73 Million USD | 12.35% |
| 2015 | 197.36 Million USD | 25.07% |
| 2014 | 157.8 Million USD | 39.08% |
| 2013 | 113.46 Million USD | 1.68% |
| 2012 | 111.58 Million USD | -19.11% |
| 2011 | 137.94 Million USD | 4.26% |
| 2010 | 132.31 Million USD | -15.93% |
| 2009 | 157.38 Million USD | -18.28% |
| 2008 | 192.58 Million USD | 10.26% |
| 2007 | 174.66 Million USD | 14.4% |
| 2006 | 152.68 Million USD | 7.31% |
| 2005 | 142.28 Million USD | -1.56% |
| 2004 | 144.54 Million USD | -13.43% |
| 2003 | 166.97 Million USD | 3.45% |
| 2002 | 161.4 Million USD | 28.25% |
| 2001 | 125.85 Million USD | 33.04% |
| 2000 | 94.59 Million USD | 107.67% |
| 1999 | 45.55 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 66.08 Million USD | -9.04% |
| 2024 Q1 | 72.65 Million USD | -15.54% |
| 2023 Q4 | 86.01 Million USD | -11.65% |
| 2023 Q3 | 97.35 Million USD | -20.94% |
| 2023 FY | 432.06 Million USD | -31.17% |
| 2023 Q2 | 123.13 Million USD | -11.68% |
| 2023 Q1 | 139.42 Million USD | 0.35% |
| 2022 Q2 | 170.4 Million USD | -2.51% |
| 2022 FY | 627.68 Million USD | 67.38% |
| 2022 Q4 | 138.94 Million USD | -3.21% |
| 2022 Q3 | 143.54 Million USD | -15.76% |
| 2022 Q1 | 174.79 Million USD | 18.79% |
| 2021 Q2 | 72.59 Million USD | 1.57% |
| 2021 Q1 | 71.46 Million USD | 31.39% |
| 2021 FY | 374.99 Million USD | 84.97% |
| 2021 Q4 | 147.15 Million USD | 75.61% |
| 2021 Q3 | 83.79 Million USD | 15.43% |
| 2020 Q3 | 48 Million USD | -5.38% |
| 2020 Q2 | 50.73 Million USD | 2.28% |
| 2020 FY | 202.73 Million USD | -0.63% |
| 2020 Q4 | 54.39 Million USD | 13.31% |
| 2020 Q1 | 49.6 Million USD | -6.69% |
| 2019 FY | 204 Million USD | -2.65% |
| 2019 Q2 | 51.58 Million USD | 6.91% |
| 2019 Q3 | 51 Million USD | -1.13% |
| 2019 Q4 | 53.16 Million USD | 4.22% |
| 2019 Q1 | 48.25 Million USD | -4.56% |
| 2018 Q3 | 51.56 Million USD | -3.96% |
| 2018 Q2 | 53.68 Million USD | -0.12% |
| 2018 FY | 209.56 Million USD | -8.32% |
| 2018 Q1 | 53.75 Million USD | -7.8% |
| 2018 Q4 | 50.55 Million USD | -1.95% |
| 2017 Q1 | 53.27 Million USD | -7.56% |
| 2017 Q2 | 56.52 Million USD | 6.11% |
| 2017 FY | 228.58 Million USD | 3.09% |
| 2017 Q3 | 60.48 Million USD | 6.99% |
| 2017 Q4 | 58.3 Million USD | -3.6% |
| 2016 Q4 | 57.63 Million USD | -0.99% |
| 2016 FY | 221.73 Million USD | 12.35% |
| 2016 Q3 | 58.21 Million USD | 6.13% |
| 2016 Q1 | 51.04 Million USD | 1.12% |
| 2016 Q2 | 54.84 Million USD | 7.44% |
| 2015 Q4 | 50.47 Million USD | -1.96% |
| 2015 Q3 | 51.48 Million USD | 6.46% |
| 2015 FY | 197.36 Million USD | 25.07% |
| 2015 Q1 | 47.03 Million USD | -1.27% |
| 2015 Q2 | 48.36 Million USD | 2.82% |
| 2014 Q1 | 30.45 Million USD | 6.61% |
| 2014 FY | 157.8 Million USD | 39.08% |
| 2014 Q4 | 47.64 Million USD | 0.77% |
| 2014 Q3 | 47.27 Million USD | 45.75% |
| 2014 Q2 | 32.43 Million USD | 6.52% |
| 2013 Q2 | 27.83 Million USD | -3.59% |
| 2013 Q3 | 28.18 Million USD | 1.24% |
| 2013 Q4 | 28.56 Million USD | 1.34% |
| 2013 FY | 113.46 Million USD | 1.68% |
| 2013 Q1 | 28.87 Million USD | 3.34% |
| 2012 Q2 | 31.86 Million USD | -5.17% |
| 2012 Q3 | 31.77 Million USD | -0.3% |
| 2012 Q4 | 27.94 Million USD | -12.05% |
| 2012 Q1 | 33.6 Million USD | -2.92% |
| 2012 FY | 111.58 Million USD | -19.11% |
| 2011 Q4 | 34.61 Million USD | -3.16% |
| 2011 FY | 137.94 Million USD | 4.26% |
| 2011 Q2 | 34.6 Million USD | 4.95% |
| 2011 Q1 | 32.97 Million USD | 1.16% |
| 2011 Q3 | 35.74 Million USD | 3.28% |
| 2010 Q4 | 32.59 Million USD | 0.52% |
| 2010 Q1 | 33.63 Million USD | -7.02% |
| 2010 Q2 | 33.65 Million USD | 0.06% |
| 2010 Q3 | 32.42 Million USD | -3.63% |
| 2010 FY | 132.31 Million USD | -15.93% |
| 2009 Q4 | 36.17 Million USD | 2.32% |
| 2009 FY | 157.38 Million USD | -18.28% |
| 2009 Q1 | 45.05 Million USD | -17.07% |
| 2009 Q2 | 40.79 Million USD | -9.46% |
| 2009 Q3 | 35.35 Million USD | -13.34% |
| 2008 Q4 | 54.33 Million USD | 14.53% |
| 2008 FY | 192.58 Million USD | 10.26% |
| 2008 Q3 | 47.43 Million USD | 3.94% |
| 2008 Q2 | 45.64 Million USD | 1.02% |
| 2008 Q1 | 45.17 Million USD | -3.29% |
| 2007 Q2 | 41.6 Million USD | 2.75% |
| 2007 Q4 | 46.71 Million USD | 1.87% |
| 2007 Q1 | 40.48 Million USD | -1.87% |
| 2007 Q3 | 45.85 Million USD | 10.23% |
| 2007 FY | 174.66 Million USD | 14.4% |
| 2006 FY | 152.68 Million USD | 7.31% |
| 2006 Q4 | 41.26 Million USD | 9.17% |
| 2006 Q1 | 37.38 Million USD | -2.92% |
| 2006 Q2 | 36.24 Million USD | -3.07% |
| 2006 Q3 | 37.79 Million USD | 4.28% |
| 2005 Q1 | 34.58 Million USD | 34.04% |
| 2005 FY | 142.28 Million USD | -1.56% |
| 2005 Q2 | 31.28 Million USD | -9.53% |
| 2005 Q3 | 37.9 Million USD | 21.17% |
| 2005 Q4 | 38.51 Million USD | 1.6% |
| 2004 FY | 144.54 Million USD | -13.43% |
| 2004 Q2 | 40.11 Million USD | -0.16% |
| 2004 Q3 | 38.45 Million USD | -4.12% |
| 2004 Q4 | 25.79 Million USD | -32.91% |
| 2004 Q1 | 40.17 Million USD | -3.39% |
| 2003 Q2 | 40.98 Million USD | 3.7% |
| 2003 Q3 | 44.87 Million USD | 9.5% |
| 2003 Q4 | 41.58 Million USD | -7.33% |
| 2003 FY | 166.97 Million USD | 3.45% |
| 2003 Q1 | 39.52 Million USD | -8.7% |
| 2002 Q2 | 40.12 Million USD | 6.43% |
| 2002 Q3 | 40.28 Million USD | 0.38% |
| 2002 Q1 | 37.7 Million USD | 4.32% |
| 2002 FY | 161.4 Million USD | 28.25% |
| 2002 Q4 | 43.29 Million USD | 7.47% |
| 2001 FY | 125.85 Million USD | 33.04% |
| 2001 Q2 | 111.35 Million USD | 0.0% |
| 2001 Q1 | 111.35 Million USD | 0.0% |
| 2001 Q3 | 34.09 Million USD | -69.38% |
| 2001 Q4 | 36.14 Million USD | 6.0% |
| 2000 FY | 94.59 Million USD | 107.67% |
| 1999 FY | 45.55 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 682.6 Million USD | 36.704% |
| Addus HomeCare Corporation | 339.87 Million USD | -27.124% |
| AirSculpt Technologies, Inc. | 121.9 Million USD | -254.426% |
| Amedisys, Inc. | 457.07 Million USD | 5.473% |
| American Oncology Network, Inc. | 66.05 Million USD | -554.076% |
| Astrana Health, Inc. | 214.95 Million USD | -100.999% |
| Aveanna Healthcare Holdings Inc. | 595.43 Million USD | 27.437% |
| IMAC Holdings, Inc. | 3.84 Million USD | -11126.445% |
| biote Corp. | 127.48 Million USD | -238.918% |
| Cryo-Cell International, Inc. | 22.9 Million USD | -1786.624% |
| COMPASS Pathways plc | -242.93 Thousand USD | 177949.081% |
| DocGo Inc. | 178.95 Million USD | -141.443% |
| The Ensign Group, Inc. | 590.75 Million USD | 26.863% |
| Healthcare Services Group, Inc. | 251.45 Million USD | -71.829% |
| InnovAge Holding Corp. | 132.06 Million USD | -227.162% |
| Assure Holdings Corp. | -2.19 Million USD | 19792.935% |
| The Joint Corp. | 107.14 Million USD | -303.233% |
| LifeStance Health Group, Inc. | 302.09 Million USD | -43.022% |
| Mobile-health Network Solutions Class A Ordinary Shares | -1.07 Million USD | 40417.736% |
| ModivCare Inc. | 446.95 Million USD | 3.331% |
| NewGenIvf Group Limited | 1.68 Million USD | -25590.739% |
| Novo Integrated Sciences, Inc. | 4.95 Million USD | -8623.761% |
| Option Care Health, Inc. | 981.22 Million USD | 55.967% |
| P3 Health Partners Inc. | 31.63 Million USD | -1265.775% |
| P3 Health Partners Inc. | 31.63 Million USD | -1265.775% |
| The Pennant Group, Inc. | 61.9 Million USD | -597.934% |
| Surgery Partners, Inc. | 529.4 Million USD | 18.386% |
| Syra Health Corp. Class A Common Stock | 1.41 Million USD | -30501.53% |
| Talkspace, Inc. | 74.38 Million USD | -480.886% |
| Talkspace, Inc. | 74.38 Million USD | -480.886% |
| The Oncology Institute, Inc. | 59.57 Million USD | -625.266% |
| The Oncology Institute, Inc. | 59.57 Million USD | -625.266% |